The effect of tofacitinib on serum lipids and cardiovascular safety in patients with ulcerative colitis: updated results from the tofacitinib ulcerative colitis clinical programme

被引：0
|
作者：
Sands, B. E. [1 ]
Taub, P. R. [2 ]
Feagan, B. G. [3 ]
Armuzzi, A. [4 ]
Damiao, A. O. [5 ]
Lawendy, N. [6 ]
Solano, G. [7 ]
Kwok, K. [8 ]
Woolcott, J. [6 ]
Salese, L. [6 ]
Su, C. [6 ]
机构：
[1] Icahn Sch Med Mt Sinai, Dr Henry D Janowitz Div Gastroenterol, New York, NY 10029 USA
[2] Univ Calif San Diego, Sch Med, Div Cardiovasc Med, La Jolla, CA USA
[3] Western Univ, Robarts Clin Trials, London, ON, Canada
[4] Univ Cattolica Sacro Cuore, Fdn Policlin Univ Gemelli IRCCS, IBD Unit, Rome, Italy
[5] Univ Sao Paulo, Dept Gastroenterol, Sao Paulo, Brazil
[6] Pfizer Inc, Collegeville, PA USA
[7] Pfizer Inc, San Jose, Costa Rica
[8] Pfizer Inc, New York, NY USA
来源：
JOURNAL OF CROHNS & COLITIS | 2020年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P684
引用
收藏
页码：S557 / S558
页数：2
相关论文
共 50 条
  • [21] Tofacitinib in Active Ulcerative Colitis
    Cottone, Mario
    Orlando, Ambrogio
    Papi, Claudio
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (20): : 1960 - 1960
  • [22] Ulcerative Colitis, Bronchiectasis and Tofacitinib
    Ansede-Bordonaba, Guillermo
    Giron-Moreno, Rosa Maria
    Martinez-Vergara, Adrian
    ARCHIVOS DE BRONCONEUMOLOGIA, 2025, 61 (03): : 180 - 181
  • [23] Integrated Safety Analyses of Tofacitinib in Ulcerative Colitis Clinical Trials
    Sandborn, William J.
    Panes, Julian
    D'Haens, Geert
    Sands, Bruce E.
    Su, Chinyu
    Moscariello, Michele
    Jones, Thomas V.
    Pedersen, Ronald D.
    Friedman, Gary S.
    Lawendy, Nervin
    Chan, Gary
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S403 - S404
  • [24] Treating ulcerative colitis with tofacitinib
    Shumeyko, Emma P.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 102 (02) : 170 - 170
  • [25] Tofacitinib for the treatment of ulcerative colitis
    Izzo, Roberta
    Bevivino, Gerolamo
    Monteleone, Giovanni
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2016, 25 (08) : 991 - 997
  • [26] Tofacitinib for the treatment of ulcerative colitis
    Fernandez-Clotet, Agnes
    Castro-Poceiro, Jesus
    Panes, Julian
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2018, 14 (11) : 881 - 892
  • [27] Venous thromboembolic events in the tofacitinib ulcerative colitis clinical development programme
    Sandborn, William J.
    Panes, Julian
    Sands, Bruce E.
    Reinisch, Walter
    Su, Chinyu
    Lawendy, Nervin
    Koram, Nana
    Fan, Haiyun
    Jones, Thomas V.
    Modesto, Irene
    Quirk, Daniel
    Danese, Silvio
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 50 (10) : 1068 - 1076
  • [28] Tofacitinib Treatment Is Associated With Modest and Reversible Increases in Serum Lipids in Patients With Ulcerative Colitis
    Sands, Bruce E.
    Taub, Pam R.
    Armuzzi, Alessandro
    Friedman, Gary S.
    Moscariello, Michele
    Lawendy, Nervin
    Pedersen, Ronald D.
    Chan, Gary
    Nduaka, Chudy I.
    Quirk, Daniel
    Salese, Leonardo
    Su, Chinyu
    Feagan, Brian G.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (01) : 123 - +
  • [29] Tofacitinib, vedolizumab and ustekinumab in patients with ulcerative colitis
    Chang, Hui-Chin
    Gau, Shuo-Yan
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 58 (11-12) : 1242 - 1242
  • [30] The role and prospect of tofacitinib in patients with ulcerative colitis
    Lee, Jun
    INTESTINAL RESEARCH, 2022,
12345